RafaelLPerezMD

Pulmonology • Philadelphia, PA

Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease, Pulmonary Rehabilitation

Professor of Medicine, University Louisville School of Medicine

Join to view full profile

Dr. Perez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Perez's full profile

Already have an account?

Office
834 Walnut St
Ste 650
Philadelphia, PA 19107
Phone+1 215-955-5161

Fax+1 215-923-6003

Education & Training

Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1989
Wright State UniversityResidency, Internal Medicine, 1982 - 1985
University of Tennessee Health Science Center College of MedicineClass of 1982

Certifications & Licensure

PA State Medical License 2018 - 2024
KY State Medical License 2010 - 2019
GA State Medical License 1985 - 2011
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Terminated
Phase 2
Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
Completed
Phase 2

Publications & Presentations

PubMed

162 citations
The Effects of Chronic Alcohol Abuse on Pulmonary Glutathione Homeostasis
Marc Moss, David M. Guidot, Monique Wong-Lambertina, Terri Ten Hoor, Rafael L. Perez
American Journal of Respiratory and Critical Care Medicine. 2000-02-01
161 citations
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.
Luca Richeldi, Evans R. Fernández Pérez, Ulrich Costabel, Carlo Albera, David J. Lederer
The Lancet. Respiratory Medicine. 2020-01-01
70 citations
Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6'-dimycolate.
Rafael L. Perez, Jesse Roman, Susanne Roser, Candice Little, Margaret Olsen
Journal of Interferon & Cytokine Research. 2000-09-01